| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |